1. Home
  2. CNC vs GEHC Comparison

CNC vs GEHC Comparison

Compare CNC & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centene Corporation

CNC

Centene Corporation

N/A

Current Price

$68.05

Market Cap

34.0B

Sector

Health Care

ML Signal

N/A

Logo GE HealthCare Technologies Inc.

GEHC

GE HealthCare Technologies Inc.

N/A

Current Price

$76.44

Market Cap

29.1B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CNC
GEHC
Founded
1984
1892
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
34.0B
29.1B
IPO Year
2001
2022

Fundamental Metrics

Financial Performance
Metric
CNC
GEHC
Price
$68.05
$76.44
Analyst Decision
Buy
Buy
Analyst Count
21
22
Target Price
$74.50
★ $86.80
AVG Volume (30 Days)
★ 3.9M
3.6M
Earning Date
10-27-2026
10-28-2026
Dividend Yield
N/A
★ 0.21%
EPS Growth
N/A
★ 4.84
EPS
★ 5.15
3.44
Revenue
★ $194,777,000,000.00
$20,625,000,000.00
Revenue This Year
$12.83
$6.01
Revenue Next Year
N/A
$4.75
P/E Ratio
★ $13.27
$22.28
Revenue Growth
★ 19.44
4.84
52 Week Low
$31.63
$58.75
52 Week High
$72.50
$89.77

Technical Indicators

Market Signals
Indicator
CNC
GEHC
Relative Strength Index (RSI) 51.54 73.86
Support Level $63.36 $68.88
Resistance Level $68.67 $85.55
Average True Range (ATR) 2.70 1.82
MACD -0.21 0.85
Stochastic Oscillator 33.09 84.85

Price Performance

Historical Comparison
CNC
GEHC

About CNC Centene Corporation

Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Share on Social Networks: